ryan braun wide getty

In focusing on Braun, Major League Baseball is abandoning the principles of its drug testing/enforcement program

36 Comments

Been doing some more thinking about the story this morning about how Major League Baseball is laser-focused on Ryan Braun in the Biogenesis investigation, to the point where it is considering giving players immunity in an effort to nab him and some of the bigger fish.

As a basic premise, I don’t have a real problem with that. This is how police work is usually done: get the small fish to flip on the big fish and so forth. I think this differs from the organized crime analogy in that here the “big fish” is only one player whose violation is no different in kind or magnitude than that of any other person cheating — and, as such, going after Braun like this is likely to cause MLB to overlook multiple more cheaters who collectively represent a greater ill to baseball than one more famous cheater — but that’s their prerogative. If they get the goods on Braun and punish him, fine, he’s punished.

All of that said, in pursuing things in such a way it’s inescapable that Major League Baseball is abandoning some of the core principles of the drug program as currently constructed.

For one thing: zero tolerance. The most adamant anti-PED folks on the planet, including WADA and USADA have spent decades telling us that zero tolerance is critical to any drug testing regime and that only through zero tolerance can you have a level competitive landscape. In singling out Braun, however, and standing willing to grant immunity to some players in order to get him, Major League Baseball is abandoning that principle. It is saying that some cheaters are more important than others. Which is the same as saying that some cheating will, in effect, be tolerated and will go unpunished.

And maybe Major League Baseball is fine with that. If so, they should say so. And if so they should cease selectively applying the standards of zero tolerance. I mean, if MLB is satisfied that it can weigh the words and determine the truthfulness of one player’s word over another’s and that it can mete out differential enforcement like this and not harm the very essence of the Joint Drug Agreement, surely it can listen to defenses of inadvertent contamination and accidental ingestion of various stimulants and PEDs, can it not? Now Bud Selig says that it can’t do that for risk of imperiling zero tolerance principles. But if the Biogenesis investigation throws such principles over the side, what is left to protect?

Also being abandoned right now: the anonymity of the testing and enforcement process.  Major League Baseball’s fixation on Braun is of such a high pitch, it appears, that it was deemed unique and newsworthy by someone privy to the process and thus was leaked to Bob Nightengale of USA Today. Since when is that acceptable? The last time news of a drug investigation/enforcement proceeding was made public it led to MLB being publicly embarrassed when that outfielder from Milwaukee beat the rap. How did that turn out for you, Mr. Selig? And how has it turned out for that outfielder, whose name will always be mud to some folks regardless of what the future holds?

If Ryan Braun cheated — and if Major League Baseball can prove it — yes, he should absolutely be punished. And at this point, if what Nightengale is reporting is true, I’d lay better odds on Braun getting popped than him getting off.  But in getting that head on a platter it’s inescapable that Major League Baseball is transforming its drug testing and enforcement regime from a clinically-based program into a police operation.  And in doing so, it appears willing to abandon zero tolerance, anonymity, uniform enforcement and everything the league tells us is so good about the Joint Drug Agreement in the first place.

Hope it’s worth it, guys.

Rangers to sign James Loney to minor league deal

SAN FRANCISCO, CA - AUGUST 21: James Loney #28 of the New York Mets tosses to first base against the San Francisco Giants during the second inning at AT&T Park on August 21, 2016 in San Francisco, California.  The New York Mets defeated the San Francisco Giants 2-0. (Photo by Jason O. Watson/Getty Images)
Getty Images
1 Comment

Free agent first baseman James Loney has reportedly signed a minor league deal with the Rangers, per FanRag Sports’ Jon Heyman. The deal includes an invite to spring training and a $1 million salary if he makes the major league roster in 2017.

Loney picked up a one-year stint and starting role with the Mets in 2016, slashing .265/.307/.397 with nine home runs in 336 PA. While his numbers were down a hair from the .280/.322/.357 batting line he produced with the Rays in 2015, he provided the Mets with a necessary, if underwhelming upgrade over an injured Lucas Duda through most of the season.

The 32-year-old infielder is expected to have some competition at first base, with at least five other candidates in the mix: Jurickson Profar, Ronald Guzman, Ryan Rua, Joey Gallo and Josh Hamilton. Rumor has it that the team is planning on platooning Rua and Profar in 2017, barring any impressive breakouts or injuries during spring training, though Loney could still provide the club with some veteran depth and a decent left-handed bat off the bench.

Report: Tyson Ross not expected to pitch in April

SAN DIEGO, CA - SEPTEMBER 29:  Tyson Ross #38 of the San Diego Padres pitches during the first inning of a baseball game against the Milwaukee Brewers at Petco Park September 29, 2015 in San Diego, California.  (Photo by Denis Poroy/Getty Images)
Getty Images
Leave a comment

Comments from an anonymous team official suggest that Rangers right-hander Tyson Ross will not be expected to join the rotation until May or June, per a report from Jeff Wilson of the Fort Worth Star-Telegram. Both Ross and GM Jon Daniels favor a conservative approach for the 29-year-old as he works his way back up to full health after undergoing surgery last October to relieve thoracic outlet syndrome.

The delay is reportedly being implemented so that Ross will be have the strength and stamina to contribute during the stretch run. Per Daniels:

We would rather err on a little extra time up front with the goal being to finish strong, pitching in big spots, meaningful games down the stretch and hopefully past 162.

Ross signed a one-year deal with the team on Thursday after pitching through an injury-riddled season with the Padres in 2016. If all goes according to plan, he’ll slot into a rotation that includes Yu Darvish, Cole Hamels, Andrew Cashner and Martin Perez. The Rangers are expected to narrow down their fifth starter alternatives in spring training.